Cargando…
The prognostic value of TPM1–4 in hepatocellular carcinoma
BACKGROUND: Despite advances in multiple disciplinary diagnoses and treatments, the prognosis of hepatocellular carcinoma (HCC) remains poor. Some evidence has identified that the aberrant expression of tropomyosins (TPMs) is involved with some cancers development. However, prognostic values of TPMs...
Autores principales: | Tian, Zhihui, Zhao, Jian, Wang, Yusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729055/ https://www.ncbi.nlm.nih.gov/pubmed/34850589 http://dx.doi.org/10.1002/cam4.4453 |
Ejemplares similares
-
Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023) -
The expression and clinical significance of TPM4 in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021) -
The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018) -
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021) -
Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)